Abstract
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.).
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | 101841 |
| Tidsskrift | JACC: Case Reports |
| Vol/bind | 14 |
| Sider (fra-til) | 1-7 |
| Antal sider | 7 |
| DOI | |
| Status | Udgivet - 17 maj 2023 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS